Stay updated with breaking news from Bernhard Schmierer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MBB core facilities and the SciLifeLab infrastructure contribute to the REMEDi4ALL project that kicks off with the ambition of establishing a European research and innovation eco-system facilitating fast and cost-effective patient-centric development and access to repurposed medicines.
(Mirror Daily, United States) – Two new studies have found that a groundbreaking DNA-editing technology called CRISPR-Cas9 could boost cancer risk in patients that use the tech to get rid of hereditary diseases. Researchers explained that the CRISPR tool can become cancer-causing when it is used to replace unhealthy genes with healthier ones. Two separate studies, one funded by Novartis and another one conducted by Sweden-based Karolinska Institutets, show that, during a CRISPR-Cas9 edit, the tweaked cells no longer have a cancer-suppressing protein dubbed p53, which can boost cancer risk. ...